Meeting the Challenge of Diabetes in China

Zhen Luo ¹ , Guilhem Fabre ², Victor G. Rodwin ³ *

Cited by CrossRef:

1- Zhu X, Yang Z, He Z, Hu J, Yin T, Bai H, Li R, Cai L, Guo H, Li M, Yan T, Li Y, Shen C, Sun K, Liu Y, Sun Z, Wang B. Factors correlated with targeted prevention for prediabetes classified by impaired fasting glucose, impaired glucose tolerance, and elevated HbA1c: A population-based longitudinal study. Front Endocrinol. 2022;13 [Crossref]

2- Wu Y, Ye R, Sun C, Meng S, Cai Z, Li L, Sylvia S, Zhou H, Pappas L, Rozelle S. Using standardized patients to assess the quality of type 2 diabetes care among primary care providers and the health system: Evidence from rural areas of western China. Front Public Health. 2022;10 [Crossref]

3- Xu X, Yang W, Deng Y, Liu L, Zhang X, Long C, Dong T, Zeng J, Kui J, Wu X. Association of socioeconomic status with glycated haemoglobin level and risk factors for diabetic retinopathy: a cross-sectional study in Sichuan, western China. BMJ Open. 2023;13(2):e067475 [Crossref]

4- Zhu J, Zhou Y, Wang G. Cost-Effectiveness of Pharmacist Care in Diabetes Management: A Systematic Review. Diabetes Ther. 2024;15(1):61 [Crossref]

5- Wu X, Li G, Liu L, Li H, Zhao Y, Golden A, Cai L. Changes in pre-diabetes and diabetes prevalence and diabetes self-management behaviors across socioeconomic spectra in rural southwest China: 2013–2022. BMC Public Health. 2025;25(1) [Crossref]

6- Diao H, Li X, Xu Y, Xing X, Pang S. Asprosin, a novel glucogenic adipokine implicated in type 2 diabetes mellitus. Journal of Diabetes and its Complications. 2023;37(11):108614 [Crossref]

7- Bragg F, Chen Z. Estimating lifetime risk of diabetes in the Chinese population. PLoS Med. 2022;19(7):e1004053 [Crossref]

8- Cong L, Pan X, Xia Y, Zhang Y, Cheng J, Dong Y. The effects of acute angle closure crisis on corneal endothelial cells in patients with type 2 diabetes mellitus. Front Endocrinol. 2022;13 [Crossref]

9- Li S, Tuerxunyiming M, Sun Z, Zheng S, Liu Q, Zhao Q. Burden of diabetes attributable to dietary cadmium exposure in adolescents and adults in China. Environ Sci Pollut Res. 2023;30(46):102353 [Crossref]

10- 吴广. Drug Utilization and Efficacy Analysis of Patients with Type 2 Diabetes Based on Real-World Medical Big Data. PI. 2024;13(03):307 [Crossref]

11- Zhang Q, Fan Y, Liu X, Zhang M, Zhang J, Du Q, Kang L, Chen L. Treatment Patterns and Glycaemic Control Between 2015 and 2019 in Tianjin, China: A Real-World Study of Adults with Type 2 Diabetes. Diabetes Ther. 2025;16(1):1 [Crossref]

12- Shao H, Tao Y, Tang C. Factors influencing bioequivalence evaluation of insulin biosimilars based on a structural equation model. Front Pharmacol. 2023;14 [Crossref]

13- Geng J, Bao H, Feng Z, Meng J, Yu X, Yu H. Investigating patients’ preferences for new anti-diabetic drugs to inform public health insurance coverage decisions: a discrete choice experiment in China. BMC Public Health. 2022;22(1) [Crossref]

14- Li X, Tan T, Wong T, Sun X. Diabetic retinopathy in China: Epidemiology, screening and treatment trends—A review. Clinical Exper Ophthalmology. 2023;51(6):607 [Crossref]

15- Moradzadeh M, Karamouzian M, Najafizadeh S, Yazdi-Feyzabadi V, Haghdoost A. International Journal of Health Policy and Management (IJHPM): A Decade of Advancing Knowledge and Influencing Global Health Policy (2013-2023). Int J Health Policy Manag. 2023;12:8124 [Crossref]

16- Zhu X, Hu J, Guo H, Ji D, Yuan D, Li M, Yan T, Xue C, Ma H, Zhou X, Liu Y, Li Y, Sun K, Liu Y, Sun Z, Wang B. Effect of Metabolic Health and Obesity Phenotype on Risk of Diabetes Mellitus: A Population-Based Longitudinal Study. DMSO. 2021;Volume 14:3485 [Crossref]

17- Zhang X, Wang Y, Li Y, Gui J, Mei Y, Yang X, Liu H, Guo L, Li J, Lei Y, Li X, Sun L, Yang L, Yuan T, Wang C, Zhang D, Li J, Liu M, Hua Y, Zhang L. Optimal obesity- and lipid-related indices for predicting type 2 diabetes in middle-aged and elderly Chinese. Sci Rep. 2024;14(1) [Crossref]

18- He Z, Li W. AI-Driven Management of Type 2 Diabetes in China: Opportunities and Challenges. DMSO. 2025;Volume 18:85 [Crossref]

19- Wang X, Ye H, Chen R, Yang S, Zhang T, Xiao W, Yang H. HbA1c: an independent risk factor for dysthyroid optic neuropathy. Front Endocrinol. 2023;14 [Crossref]

20- Shi L, Zou X, Dai C, Ji Z. Uniting Multi-Scale Local Feature Awareness and the Self-Attention Mechanism for Named Entity Recognition. Mathematics. 2023;11(11):2412 [Crossref]

21- Huang M, Hu L, Chen J, Cao F. In vitro testing indicates an accelerated rate of digestion of starch into glucose of cooked rice with the development of low amylose rice in China. Food Chemistry: X. 2022;14:100278 [Crossref]

22- Song K, Zhang D, Shi L, Francis M, Han Z, Pan X, Hou Z. Trends and disparities in diabetes care following China's healthcare reform: Evidence from the 2011–12 and 2015–16 China Health and Retirement Longitudinal Study. Preventive Medicine. 2022;156:106982 [Crossref]

23- Lin Y, Shen Y, He R, Wang Q, Deng H, Cheng S, Liu Y, Li Y, Lu X, Shen Z. A novel predictive model for optimizing diabetes screening in older adults. J of Diabetes Invest. 2024;15(10):1403 [Crossref]

24- Ji L, Lu Y, Li Q, Fu L, Luo Y, Lei T, Li L, Ye S, Shi B, Li X, Meinicke T. Efficacy and safety of empagliflozin in combination with insulin in Chinese patients with type 2 diabetes and insufficient glycaemic control: A phase III, randomized, double‐blind, placebo‐controlled, parallel study. Diabetes Obesity Metabolism. 2023;25(7):1839 [Crossref]

25- Meripour M, Khafaie M, mohamadian H. Designing health promoting lifestyle educational content using photovoice qualitative approach in pre-diabetic people: A community-based participatory research. Payesh. 2021;20(1):49 [Crossref]

26- Li Y, Shen H, Li Y, Bi M, Bi Y, Che X, Tian S, Liu Y. Sex-Specific Differences in the Associations Between Omega-6 Polyunsaturated Fatty Acids and Type 2 Diabetes in Chinese People. Front Nutr. 2021;8 [Crossref]

27- Kovalevska I, Ruban O, Volkova A, Kotvitska A, Cherkashyna A. The use of complex marketing analysis and QSPR methodology for the necessity of a drug development grounding for the treatment of type 2 diabetes mellitus with increased bioavailability. PHAR. 2022;69(2):303 [Crossref]

28- Zhang S, Yan H, Cao D, Sun W, Li J, Xu J, Song B, Wu X. Research hotspots and trends in diabetes and insulin resistance: a bibliometric analysis. Front Nutr. 2024;11 [Crossref]

29- Bakkali S, Taeymans J, Senior C, Dirinck E, Vereeck L, Vissers D. Does diabetes mellitus type 2 affect vestibular function? A systematic review and meta-analysis. Diabetes Epidemiology and Management. 2021;4:100035 [Crossref]

30- Zheng Z, Xu S, Zhu J, Yang Q, Ye H, Li M, Zhang X, Liu H, Cheng Y, Zou Y, Lu Y, Wang P. Disease burden of cancers attributable to high fasting plasma glucose from 1990 to 2021 and projections until 2031 in China. Cancer Epidemiology. 2025;94:102725 [Crossref]

31- Ma X, Fan W, Zhang X, Zhang S, Feng X, Song S, Wang H. The urban-rural disparities and factors associated with the utilization of public health services among diabetes patients in China. BMC Public Health. 2023;23(1) [Crossref]

32- Yang T, Yang Q, Zhou Y, Wen C. Glucose trend prediction model based on improved wavelet transform and gated recurrent unit. MBE. 2023;20(9):17037 [Crossref]

33- Wu Y, Xu Y, Deng H, Sun J, Li X, Tang J. Poricoic acid a ameliorates high glucose-induced podocyte injury by regulating the AMPKα/FUNDC1 pathway. Mol Biol Rep. 2024;51(1) [Crossref]

34- Lu J, Yang H, Shi L, Sheng X, Huo Y, Liu R, Hu R. Associations between Primary Healthcare Experiences and Glycemic Control Status in Patients with Diabetes: Results from the Greater Bay Area Study, China. IJERPH. 2023;20(2):1120 [Crossref]

35- Hu T, Zhang W, Han F, Zhao R, Liu H, An Z. Machine learning reveals serum myristic acid, palmitic acid and heptanoylcarnitine as biomarkers of coronary artery disease risk in patients with type 2 diabetes mellitus. Clinica Chimica Acta. 2024;556:117852 [Crossref]

36- Lv Y, Qin J, Feng X, Li S, Tang C, Wang H. Preferences of patients with diabetes mellitus for primary healthcare institutions: a discrete choice experiment in China. BMJ Open. 2023;13(6):e072495 [Crossref]

37- Huang M, Li L, Cao F, Chen J, Wang W, Zheng H. Differences in starch digestive properties of cooked rice between four older and four current varieties. Food Nutr Health. 2025;2(1) [Crossref]

38- Bradley S, Varghese F, Menon B, Mehndiratta M, Bhaskar S. Stroke in Patients with Diabetes: Is It Time to Expand Public Health Priority to Encompass High-Risk Patients with Increased Insulin Resistance?. EMJ Diabet. 2021;:84 [Crossref]

39- Xing X, Wang X, Fang X, Xu J, Chen Y, Xu W, Wang H, Liu Z, Tao S. Glycemic control and its influencing factors in type 2 diabetes patients in Anhui, China. Front Public Health. 2022;10 [Crossref]

Submit Your Paper Archive